Results 171 to 180 of about 364,170 (283)
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C [PDF]
Marcus Wiedmann+8 more
openalex +1 more source
Summary Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus causing COVID‐19, has been spreading and mutating globally despite the expedited approval of many commercial vaccines. Therefore, developing safe, effective and affordable vaccines remains essential to meet the global demand, particularly in developing countries.
Li Song+14 more
wiley +1 more source
Hepatitis B vaccine coverage in health care students: a cross-sectional study in Vietnam. [PDF]
Vo LT+6 more
europepmc +1 more source
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer [PDF]
S. Zucchelli+10 more
openalex +1 more source
Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers. [PDF]
Williams AL, Newman RS.
europepmc +1 more source
Severe pancytopenia triggered by recombinant hepatitis B vaccine [PDF]
Jean‐François Viallard+7 more
openalex +1 more source
Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth [PDF]
N. Linder
openalex +1 more source
Attitudes of the Population Toward Vaccines During the COVID‐19 Pandemic: The PROACTIVE Study
ABSTRACT Background Vaccination is a vital strategy to prevent infectious diseases and reduce mortality globally. However, vaccine hesitancy threatens these efforts, especially highlighted during the COVID‐19 pandemic. Understanding factors influencing vaccination decisions is crucial for improving public health strategies.
Michela Calzolari+8 more
wiley +1 more source